KeyBanc Starts Medidata Solutions (MDSO) at Overweight

KeyBanc initiated coverage on Medidata Solutions (NASDAQ: MDSO) with an Overweight rating and a price target of $60.

Analyst Donald Hooker said, "We are initiating coverage of Medidata Solutions, Inc. (MDSO) with an Overweight rating and a price target of $60 per share, implying 25.8x our 2016 EBITDA estimate of $122M. MDSO develops and markets software, data analytics and services across a single-instance, multi-tenant cloud platform that streamlines clinical research and drug development. In our view, MDSO is positioned to benefit from the increasing use of informatics in clinical trials and a more clinically driven reimbursement environment in healthcare."

For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.

Shares of Medidata Solutions closed at $47.42 yesterday.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Adobe (ADBE) PT Lowered to $225 at UBS Amid Plans to Pivot to Freemium Model
• Freedom Broker Starts CarGurus Inc. (CARG) at Buy